| Name | Title | Contact Details |
|---|
Maven is the largest virtual clinic for women`s and family health, offering continuous, holistic care for fertility, pregnancy, and parenting. Maven`s award-winning digital programs are trusted by leading employers and health plans to reduce costs and drive better health outcomes for both parents and children. Founded in 2014 by CEO Kate Ryder, Maven has been recognized as Fast Company`s #1 Most Innovative Health Company and has supported more than 10 million women and families to date. Maven has raised $92 million in funding from leading investors including Sequoia, Oak HC/FT, and Female Founders Fund.
At Indi we believe that a systems-based approach is necessary to understand complex diseases and improve health. Our mission is to dramatically improve diagnosis and management of complex diseases by building advanced molecular diagnostics and creating new diagnostic technologies. We seek to understand the complex biological systems from which diseases arise so that we can determine which combinations of biomarkers have the greatest diagnostic power. Then we build assays capable of measuring hundreds of proteins at a time, for more precise detection and management of disease. Our end goal is to create large-scale systems medicine diagnostics that can gather a wealth of information – and then make sense of that information so that physicians can better diagnose disease.
The American Physical Therapy Associations top-ranked private physical therapy practice, and the top-rated physical therapists in New York City.
Biological Dynamics Inc. is an early stage company that has developed a proprietary AC Electrokinetic technology to rapidly extract nanoparticles in high-conductance physiological solutions. Biological Dynamics was founded in 2008 by Raj Krishnan and David Charlot, Bioengineering PHD graduates from the University of California, San Diego (UCSD). Our vision is to enable healthcare practitioners to detect, diagnose and monitor cancer and other diseases from a simple blood draw (or other bodily fluid) and rapidly intervene, increasing patient survivability while driving down the total burden costs.